Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Clinical Effects of Low-Intensity Focused Ultrasound Neuromodulation in Patients With Neurological and Psychiatric Disorders

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Low intensity focused ultrasound (LIFUS) has the potential to be used as a means of non-invasive neuro-modulation. To this day, the use of LIFUS is under investigation. Studies in healthy subjects have shown that application of LIFUS to the motor region of the brain can mildly decrease neuron excitability in healthy controls. The purpose of the present study is to evaluate the effects of LIFUS on brain tissue excitability in patients with movement disorders in order to elucidate the therapeutic potential of LIFUS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• 18-85 years of age

• Patients diagnosed with neurological disorders, (such as epilepsy, brain tumour, movement disorders) or psychiatric disorders (such as substance abuse disorder)

• Patients undergoing medical or surgical treatment (such as DBS) for neurological disorders

Locations
Other Locations
Canada
Toronto Western Hospital, 399 Bathurst St
RECRUITING
Toronto
Time Frame
Start Date: 2025-12-02
Estimated Completion Date: 2040-12-31
Participants
Target number of participants: 50
Treatments
Experimental: Active LIFUS
Participants receive low-intensity focused ultrasound neuromodulation (LIFUS) targeting cortical or subcortical brain regions, with or without concurrent TMS or EEG/DBS recordings, depending on the study component.
Placebo_comparator: Sham LIFUS
Participants receive sham LIFUS stimulation designed to mimic the experimental condition without delivering therapeutic ultrasound energy.
Sponsors
Leads: University Health Network, Toronto

This content was sourced from clinicaltrials.gov